Last week, I showed you just how profitable "frontier investing" can be.
It's a deceptively simple, powerful approach I take for my Nova-X Report readers: Research a good investment, build a thesis, target the best stock before Street analysts know it exists, and let the profits come to you as the crowd piles in.
Silicon Valley is a hotbed of this kind of investing; one where my readers have been able to make a killing. Biotech and the life sciences are two others.
Cannabis investing is the latest and most profitable.
It's easier now than it's ever been to get wired into the growth.
And, thanks to what I'm about to show you, there's plenty of that on the way…
The Broadest Exposure to a Booming Sector
As recently as 2013, legally sanctioned "medical marijuana" was worth about $1.5 billion in sales.
But in 2017 – when more than half the states in the Union have some form of legal medical or recreational use laws – the cannabis sector will be worth $6.7 billion… $35 billion by 2020… and $100 billion by 2029.
That represents huge, long-term profit potential for investors on the "frontier" right now.
There's been a new development, though, that, as I said, makes it easy to tap into the upside here.
Even better, it represents a massive leap forward in the credibility of the entire cannabis sector – irresistible bait for the "crowd" who are going to pour in and boost early investor profits.
You see, cannabis just joined the ETF game.
This week marked the historic launch of the Horizons Medical Marijuana Life Sciences ETF (TSE: HMMJ) on the Toronto Stock Exchange.
This first-of-its-kind fund is composed of 14 Canadian and U.S. cannabis stocks.
A marijuana ETF offers a "one-stop shot" for broad sector exposure. What's more, it can limit losses and maximize upside, and, therefore, it offers one safe way to play the $6.7 billion North American cannabis market.
ETFs help protect investors through diversification that offsets losses from single stocks – after all, some marijuana stocks can be volatile.
But there's also plenty of "upside volatility"; I've seen individual weed stocks across the market zoom as much as 1,016%, 630%, 243%, 182%, and 158%.
About the Author
Michael A. Robinson is a 36-year Silicon Valley veteran and one of the top tech and biotech financial analysts working today. That's because, as a consultant, senior adviser, and board member for Silicon Valley venture capital firms, Michael enjoys privileged access to pioneering CEOs, scientists, and high-profile players. And he brings this entire world of Silicon Valley "insiders" right to you...
- He was one of five people involved in early meetings for the $160 billion "cloud" computing phenomenon.
- He was there as Lee Iacocca and Roger Smith, the CEOs of Chrysler and GM, led the robotics revolution that saved the U.S. automotive industry.
- As cyber-security was becoming a focus of national security, Michael was with Dave DeWalt, the CEO of McAfee, right before Intel acquired his company for $7.8 billion.
This all means the entire world is constantly seeking Michael's insight.
In addition to being a regular guest and panelist on CNBC and Fox Business, he is also a Pulitzer Prize-nominated writer and reporter. His first book Overdrawn: The Bailout of American Savings warned people about the coming financial collapse - years before the word "bailout" became a household word.
Silicon Valley defense publications vie for his analysis. He's worked for Defense Media Network and Signal Magazine, as well as The New York Times, American Enterprise, and The Wall Street Journal.
And even with decades of experience, Michael believes there has never been a moment in time quite like this.
Right now, medical breakthroughs that once took years to develop are moving at a record speed. And that means we are going to see highly lucrative biotech investment opportunities come in fast and furious.
To help you navigate the historic opportunity in biotech, Michael launched the Bio-Tech Profit Alliance.
His other publications include: Strategic Tech Investor, The Nova-X Report, Bio-Technology Profit Alliance and Nexus-9 Network.